Taylor Wessing

Taylor Wessing is an international law firm with significant expertise in advising companies in the life sciences, biotech, pharmaceutical, and healthcare sectors. The firm supports clients with legal matters including IP protection/litigation, regulatory compliance, M&A transactions, licensing/collaborations, clinical trial agreements and venture capital fundraising. It does not have its own clinical pipeline or therapeutic programs. The firm's clients include global pharmaceutical corporations as well as start-ups and investors in the health/life science space. Notable recent work includes advising Apollo Therapeutics on its $226.5 million Series C fundraising and AlveoGene on its spinout from leading UK academic institutions. Taylor Wessing has one of Europe's largest specialist biotech teams supporting companies at all stages of development. The firm also operates Synapse—a content hub for pharma/biotech/medtech legal insights. Offices span Europe, Asia-Pacific, Middle East and USA. No direct involvement in product R&D or commercialization. Recognized for excellence in cross-border transactions/IP litigation within regulated industries such as pharmaceuticals/biotech.